Delivery Order SPE2DB20D7059-SPE2DB24FQCB1
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $19K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $53,889.29 contract has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract with DLA that serves as the primary vehicle for the company to deliver...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,564,353 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a ceiling value of $36,781.92 and an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,288.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564288248 Boostrix TDAP vaccine syringes. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC enables the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,265.40 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product and has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $33,555.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a potential value of $12,697.79 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $34,210.56 order is in support of DLA Troop Support Medical programs and facilities, and will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,433,659 units of the BOOSTRIX TDAP vaccine syringe 0.5ML. The $2,379.90 contract has a completion date of January 25, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies, and distribution services to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price valued at $1,021.72, for the provision of the BOOSTRIX TDAP vaccine syringe 0.5 mL. The ultimate completion date is March 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,842.51 firm fixed price delivery order is for the supply of BOOSTRIX TDAP vaccine syringes to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...